COMMUNIQUÉS West-GlobeNewswire

TerrAscend Reschedules November 6th Third Quarter 2025 Earnings Conference Call to Pre-Open from Post-Market Close
22/10/2025
TORONTO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis company, today announced that it has rescheduled its November 6 [...]
Calidi Biotherapeutics Announces Establishment of Scientific Advisory Board to Support Development of CLD-401 and Advance its RedTail Platform for the Systemic Delivery of Targeted Genetic Medicine
22/10/2025
SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, [...]
LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program
22/10/2025
Renowned Menopause and Hormone Specialist to Help Guide and Represent LifeMD’s Comprehensive and Personalized Care Offering for Women NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading [...]
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
22/10/2025
STOUGHTON, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have poster presentations highlighting real-world data from its differentiated neuropsychiatry [...]
Aardvark Therapeutics to Present Data on Pipeline Programs at Upcoming ObesityWeek
22/10/2025
Aardvark to host Investor Webinar with members of the management team, leading key opinion leaders and patient advocates on November 5, 2025 SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. ( [...]
R1 Launches Phare, Healthcare’s First Revenue Operating System
22/10/2025
Delivers on R1’s Long-Term Investments in People and Technology to Transform the Revenue Cycle Through Sustained, AI-Driven Innovation R1 Enters Exclusive Partnership with Singing River Health System to Implement Phare [...]
DLH Demonstrates Cybersecurity Excellence with CMMC Level 2 Certification
22/10/2025
ATLANTA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science [...]
Alignment Health Plan Named a 2026 Best Insurance Company for Medicare Advantage Across All Its Markets by U.S. News & World Report
22/10/2025
Company earns “Best” ranking in Arizona, California, Nevada, North Carolina and Texas, reflecting strong performance in care quality, prevention and satisfaction ORANGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- [...]
Synergy CHC (NASDAQ: SNYR) Deepens FOCUSfactor® Expansion with Kroger, PriceSmart & Wakefern — Strengthening U.S., Canada, and Global Reach
22/10/2025
WESTBROOK, Maine, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR ), a leading consumer health and wellness company , today announced a series of major retail authorizations and distribution [...]
Noah Medical Expands Clinical Evidence for the Galaxy System With Two New Studies Presented at CHEST 2025
22/10/2025
Data from leading healthcare centers reinforce high diagnostic accuracy, workflow efficiency, and cost-effectiveness of robotic-assisted bronchoscopy with embedded imaging technology SAN CARLOS, Calif., Oct. 22, 2025 ( [...]
CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%
22/10/2025
SINGAPORE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary [...]
Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development
22/10/2025
Nasir Khan, DVM, Ph.D.: Senior Vice President of Preclinical Development Gary Ingenito, MD, Ph.D.: Senior Vice President of Clinical Development WALTHAM, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Sironax, a global [...]
Kyverna Therapeutics to Host Conference Call on Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis
22/10/2025
EMERYVILLE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, [...]
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning
22/10/2025
PLAN CALCIUM study to be presented at TCT 2025 conference highlights how AI-powered plaque analysis can inform lesion preparation and calcium modification planning NAVIGATE-PCI registry to enroll approximately 2,500 [...]
Madrigal Pharmaceuticals to Release Third-Quarter 2025 Financial Results and Host Webcast on November 4, 2025
22/10/2025
CONSHOHOCKEN, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET
22/10/2025
BRISBANE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients [...]
Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones
22/10/2025
Company to host shareholder webinar today, October 22, 2025, at 2:00 PM ET to review execution milestones, pipeline progress, and capital strategy WESTLAKE VILLAGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Turn [...]
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
22/10/2025
Virtual webinar to feature expert insights on unmet need, treatment landscape and potential clinical utility of Aryl Hydrocarbon Receptor (AhR) modulation in ulcerative colitis LA JOLLA, Calif., Oct. 22, 2025 (GLOBE [...]
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors
22/10/2025
AUSTIN, Texas, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for central nervous [...]

Pages